- Previous Close
2.7890 - Open
2.7405 - Bid 2.7205 x --
- Ask 2.7370 x --
- Day's Range
2.7040 - 2.7405 - 52 Week Range
1.9040 - 2.8215 - Volume
28,686 - Avg. Volume
612,793 - Market Cap (intraday)
709.546M - Beta (5Y Monthly) 0.98
- PE Ratio (TTM)
11.39 - EPS (TTM)
0.2400 - Earnings Date Feb 25, 2025
- Forward Dividend & Yield 0.02 (0.69%)
- Ex-Dividend Date Apr 24, 2025
- 1y Target Est
4.61
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source through traditional channels. It is also involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals and veterinary surgeons; operates a network of pharmacies under the Life, Allcare, Hickey's, and McCauley brands. In addition, the company provides pharmacy support, pharmaceutical supply chain and services, medical device distribution, specialist nursing and infusion, outsourcing and resourcing, healthcare technology, medical affairs, online pharmacy and product fostering, and telecommunications support services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
www.uniphar.ie3,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: UPR.IR
View MorePerformance Overview: UPR.IR
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is ISEQ All Share (^ISEQ) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UPR.IR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UPR.IR
View MoreValuation Measures
Market Cap
723.95M
Enterprise Value
1.03B
Trailing P/E
11.87
Forward P/E
12.63
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.27
Price/Book (mrq)
1.80
Enterprise Value/Revenue
0.37
Enterprise Value/EBITDA
7.53
Financial Highlights
Profitability and Income Statement
Profit Margin
2.32%
Return on Assets (ttm)
4.04%
Return on Equity (ttm)
17.47%
Revenue (ttm)
2.77B
Net Income Avi to Common (ttm)
64.2M
Diluted EPS (ttm)
0.2400
Balance Sheet and Cash Flow
Total Cash (mrq)
102.99M
Total Debt/Equity (mrq)
101.06%
Levered Free Cash Flow (ttm)
5.83M